Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | KYPROLIS® (carfilzomib) for Relapsed Multiple Myeloma Treatment |
Description | KYPROLIS® (carfilzomib) is a treatment option for people who have already received 1 or more previous treatments for relapsed multiple myeloma. Learn more here. |
Keywords |
WebSite | www.kyprolis.com |
Host IP | 54.191.55.152 |
Location | Boardman, Oregon, United States |
Site | Rank |
kyprolis-hcp.com | #1,704,873 |
amgenassist360.com | #7,499,890 |
velcade.com | #1,652,008 |
US$18,789
Last updated: Apr 29, 2020
Kyprolis.com has global traffic rank of 1,816,579. Kyprolis.com has an estimated worth of US$ 18,789, based on its estimated Ads revenue. Kyprolis.com receives approximately 1,715 unique visitors each day. Its web server is located in Boardman, Oregon, United States, with IP address 54.191.55.152. According to SiteAdvisor, kyprolis.com is safe to visit. |
Purchase/Sale Value | US$18,789 |
Daily Ads Revenue | US$10 |
Monthly Ads Revenue | US$308 |
Yearly Ads Revenue | US$3,757 |
Daily Unique Visitors | 1,715 |
Note: All traffic and earnings values are estimates. |
Global Rank | 1,816,579 |
Delta (90 Days) | 0 |
Most Popular In Country | N/A |
Country Rank | N/A |
Host | Type | TTL | Data |
kyprolis.com | A | 59 | IP: 34.209.10.117 |
kyprolis.com | A | 59 | IP: 54.191.55.152 |
kyprolis.com | MX | 299 | Priority: 20 Target: a-0018ee01.gslb.pphosted.com. |
kyprolis.com | MX | 299 | Priority: 10 Target: a-0018ee01.gslb.pphosted.com. |
kyprolis.com | NS | 21599 | Target: ns-1903.awsdns-45.co.uk. |
kyprolis.com | NS | 21599 | Target: ns-241.awsdns-30.com. |
kyprolis.com | NS | 21599 | Target: ns-534.awsdns-02.net. |
kyprolis.com | NS | 21599 | Target: ns-1173.awsdns-18.org. |
kyprolis.com | SOA | 899 | MNAME: ns-1903.awsdns-45.co.uk. RNAME: awsdns-hostmaster.amazon.com. Serial: 1 Refresh: 7200 Retry: 900 Expire: 1209600 Minimum TTL: 86400 |
HTTP/1.1 301 Moved Permanently Date: Wed, 29 Apr 2020 05:09:14 GMT Content-Type: text/html; charset=UTF-8 Content-Length: 144 Connection: keep-alive Set-Cookie: AWSALB=3dWvuubhshLpTsygNlqlpNqzOUetfeEL5LpzH0Gg9++n1LBSCZ/urZJdKYtrFq6MnvMtBv9k+VUfrU1MyPYk27HiUnzb8drebKlGiccZ0Swuf/XJsT5vAWM2hY6L; Expires=Wed, 06 May 2020 05:09:14 GMT; Path=/ Set-Cookie: AWSALBCORS=3dWvuubhshLpTsygNlqlpNqzOUetfeEL5LpzH0Gg9++n1LBSCZ/urZJdKYtrFq6MnvMtBv9k+VUfrU1MyPYk27HiUnzb8drebKlGiccZ0Swuf/XJsT5vAWM2hY6L; Expires=Wed, 06 May 2020 05:09:14 GMT; Path=/; SameSite=None Location: https://kyprolis.com/ Content-Security-Policy: frame-ancestors 'self' http://www.medscape.com https://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com X-Frame-Options: ALLOW-FROM http://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com X-Xss-Protection: 1; mode=block HTTP/2 301 date: Wed, 29 Apr 2020 05:09:15 GMT content-type: text/html; charset=UTF-8 content-length: 148 location: https://www.kyprolis.com/ set-cookie: AWSALB=7uuEGBYjHLlq9r/bzX6ElwDUZn/FQ3XYUPV7VlEnpJzv41TWVt/I+5s+HNBfeFmyLAOrwjbEitlwmkjuC38wkNhmrYz6IWobouwPhHUe/TKs6iVOPg0GKgc99wue; Expires=Wed, 06 May 2020 05:09:15 GMT; Path=/ set-cookie: AWSALBCORS=7uuEGBYjHLlq9r/bzX6ElwDUZn/FQ3XYUPV7VlEnpJzv41TWVt/I+5s+HNBfeFmyLAOrwjbEitlwmkjuC38wkNhmrYz6IWobouwPhHUe/TKs6iVOPg0GKgc99wue; Expires=Wed, 06 May 2020 05:09:15 GMT; Path=/; SameSite=None; Secure content-security-policy: frame-ancestors 'self' http://www.medscape.com https://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com x-frame-options: ALLOW-FROM http://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com x-xss-protection: 1; mode=block HTTP/2 200 date: Wed, 29 Apr 2020 05:09:15 GMT content-type: text/html; charset=utf-8 content-length: 20830 set-cookie: AWSALB=WCdgd/PWkGivosk8S8TPUvFBN8Zn0UlPA2XDGxDGbDz1zWyLmotsp2CzMk72j5W3QluDGi+EgRuAh00cIYzClUyFMShQ/GuwtOmFfWljH+jP2C991ElXpR7GYJEz; Expires=Wed, 06 May 2020 05:09:15 GMT; Path=/ set-cookie: AWSALBCORS=WCdgd/PWkGivosk8S8TPUvFBN8Zn0UlPA2XDGxDGbDz1zWyLmotsp2CzMk72j5W3QluDGi+EgRuAh00cIYzClUyFMShQ/GuwtOmFfWljH+jP2C991ElXpR7GYJEz; Expires=Wed, 06 May 2020 05:09:15 GMT; Path=/; SameSite=None; Secure cache-control: private x-aspnetmvc-version: 5.1 content-security-policy: frame-ancestors 'self' http://www.medscape.com https://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com x-frame-options: ALLOW-FROM http://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com x-xss-protection: 1; mode=block |
Domain Name: KYPROLIS.COM Registry Domain ID: 1596794375_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2020-04-09T09:14:58Z Creation Date: 2010-05-11T17:36:54Z Registry Expiry Date: 2022-05-11T17:36:54Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-1173.AWSDNS-18.ORG Name Server: NS-1903.AWSDNS-45.CO.UK Name Server: NS-241.AWSDNS-30.COM Name Server: NS-534.AWSDNS-02.NET DNSSEC: unsigned URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/ Domain Name: kyprolis.com Registry Domain ID: 1596794375_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2020-04-09T02:14:58-0700 Creation Date: 2010-05-11T10:36:54-0700 Registrar Registration Expiration Date: 2022-05-11T00:00:00-0700 Registrar: MarkMonitor, Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895770 Domain Status: clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited) Domain Status: clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited) Domain Status: clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited) Registrant Organization: Onyx Pharmaceuticals, Inc. Registrant State/Province: CA Registrant Country: US Registrant Email: Select Request Email Form at https://domains.markmonitor.com/whois/kyprolis.com Admin Organization: Onyx Pharmaceuticals, Inc. Admin State/Province: CA Admin Country: US Admin Email: Select Request Email Form at https://domains.markmonitor.com/whois/kyprolis.com Tech Organization: Onyx Pharmaceuticals, Inc. Tech State/Province: CA Tech Country: US Tech Email: Select Request Email Form at https://domains.markmonitor.com/whois/kyprolis.com Name Server: ns-1173.awsdns-18.org Name Server: ns-241.awsdns-30.com Name Server: ns-1903.awsdns-45.co.uk Name Server: ns-534.awsdns-02.net DNSSEC: unsigned URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/ MarkMonitor Domain Management(TM) Protecting companies and consumers in a digital world. Visit MarkMonitor at https://www.markmonitor.com Contact us at +1.8007459229 In Europe, at +44.02032062220 |